Daunoxome (DNX, Nexstar) was given, as a single agent, to 11 patients with very poor-risk acute leukemia. Pharmacokinetic data were also obtained from 9 of the 11 cases. This small pilot study show that the toxic profile of this liposomal-encapsulated anthracycline is low.
|Number of pages||2|
|Publication status||Published - 2000|
- Acute leukemia
ASJC Scopus subject areas